Search details
1.
Disrupting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapy.
bioRxiv
; 2024 Mar 26.
Article
in English
| MEDLINE | ID: mdl-38405985
2.
Metabolic predictors of response to immune checkpoint blockade therapy.
iScience
; 26(11): 108188, 2023 Nov 17.
Article
in English
| MEDLINE | ID: mdl-37965137
Results
1 -
2
de 2
1
Next >
>>